Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Osteoporosis, Post-Menopausal Clinical Trial

Official title:
Efficacy and Safety of Teriparatide 20 Micrograms in the Treatment of Postmenopausal Women With Osteoporosis

Status Completed

Clinical Trial Summary

To see if using teriparatide for 12 months will increase Bone Mineral Density at the lumbar spine in postmenopausal women with osteoporosis

n/a

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Completed	`NCT00018447` - Combination Osteogenic Therapy in Established Osteoporosis	Phase 2
Completed	`NCT00532246` - Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo	Phase 4
Completed	`NCT00543023` - A Study of the Treatment of Postmenopausal Women With Osteoporosis	Phase 3
Completed	`NCT00927186` - Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women	Phase 4
Completed	`NCT00543218` - PTH Comparison in Post Menopausal Women	Phase 3
Completed	`NCT00532428` - Long Term Effects of Raloxifene Treatment on Bone Quality	Phase 4
Completed	`NCT00532545` - Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis	Phase 4